Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibodies in Drug Discovery

Simon Hufton's Biography



Simon Hufton, Principle Scientist, National Institute for Biological Standard and Control

Dr Simon E. Hufton joined NIBSC in 2009 as a principal scientist within the Biotherapeutics division. He has over 20-years’ experience in the therapeutic monoclonal antibody field including the biopharmaceutical industry as Director Research for Dyax (Liege, Belgium) and Wyeth (Dublin, Ireland). He is a biochemist by training and received his undergraduate degree from The University of Manchester, UK and his PhD at Nottingham University, UK. His research interests include therapeutic monoclonal antibody discovery, optimisation and development with a particular emphasis on antibody structure/function related to the efficacy quality and safety of biological medicines.

Simon Hufton Image

Cross-Neutralising Single Domain Antibodies to Influenza – Preparing for the Next Pandemic

Monday, 6 March 2017 at 09:30

Add to Calendar ▼2017-03-06 09:30:002017-03-06 10:30:00Europe/LondonCross-Neutralising Single Domain Antibodies to Influenza – Preparing for the Next PandemicSELECTBIOenquiries@selectbiosciences.com

Single domain antibodies (nanobodies) and their applications to influenza vaccine potency testing and immunotherapy will be discussed.


Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAntibodies in Drug DiscoverySELECTBIOenquiries@selectbiosciences.com